2019 Back Orders on Methylphenidate: A Growing Concern

Methylphenidate, also known as Ritalin or Concerta, is a widely prescribed medication used to treat attention deficit hyperactivity disorder (ADHD). However, the increasing demand for this medication has led to back orders in 2019, leaving many patients without access to their necessary treatment.

One of the most significant concerns surrounding methylphenidate is its potential for abuse and misuse. The drug has a high potential for addiction, which can lead to serious side effects, including cardiovascular problems, such as fast, pounding, or irregular heartbeat or pulse. Additionally, users may experience decreased interest in sexual intercourse, chest discomfort, tightness, or heaviness, uncontrolled vocal outbursts or tics, scaling, severe redness, soreness, or swelling of the skin, crusting, dryness, or flaking of the skin, and blurred vision or other changes in vision.

In fact, according to the manufacturer's warning label, methylphenidate may cause serious side effects that require immediate medical attention. These include fast, pounding, or irregular heartbeat or pulse; decreased interest in sexual intercourse; chest discomfort, tightness, or heaviness; uncontrolled vocal outbursts or tics; scaling, severe redness, soreness, or swelling of the skin; crusting, dryness, or flaking of the skin; and blurred vision or other changes in vision.

Moreover, the misuse and abuse of CNS stimulants like methylphenidate can lead to overdose and death. This risk is increased with higher doses or unapproved methods of administration, such as snorting or injection.

The increasing back orders on methylphenidate are a growing concern for patients and healthcare providers alike. To address this issue, it is essential to educate patients and their families about the risks associated with methylphenidate misuse and abuse. Patients should also be advised on proper storage and disposal of the drug to prevent diversion and abuse.

In conclusion, the 2019 back orders on methylphenidate highlight the need for increased vigilance and education around the potential risks associated with this medication. By understanding these risks and taking steps to prevent misuse and abuse, we can ensure that patients have access to necessary treatment while also protecting public health.